Showing results (141-150 of 206) with videos related to

Sort By:
Pageof 21
The Lancet. Neurology|December 14, 2007
Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trialSteven L Wolf, Carolee J Winstein, J Phillip Miller, et al.
Journal of Clinical Immunology|June 2, 2023
Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary ImmunodeficienciesNiraj C Patel, Troy Torgerson, Monica S Thakar, et al.
Journal of Clinical Psychopharmacology|February 25, 2011
Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medicationShawn M McClintock, Mustafa M Husain, Stephen R Wisniewski, et al.
Therapeutic Advances in Respiratory Disease|November 29, 2025
Randomized, phase I studies to evaluate the safety, tolerability, and pharmacokinetics of an inhaled, TMEM16A potentiator, GDC-6988, in healthy subjectsPaul Miller, Daniel Repplinger, Rui Zhu, et al.
Journal of Clinical Immunology|September 5, 2015
Subcutaneous Immunoglobulin Replacement Therapy with Hizentra® is Safe and Effective in Children Less Than 5 Years of AgeNiraj C Patel, Joel L Gallagher, Hans D Ochs, et al.
Neurorehabilitation and Neural Repair|July 10, 2010
Measurement structure of the Wolf Motor Function Test: implications for motor control theoryMichelle Woodbury, Craig A Velozo, Paul A Thompson, et al.
Journal of the American Chemical Society|October 30, 2020
Anisotropic Strain Tuning of L10 Ternary Nanoparticles for Oxygen ReductionJunrui Li, Shubham Sharma, Kecheng Wei, et al.
The International Journal of Neuropsychopharmacology|December 2, 2011
Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED reportHerng Nieng Chan, A John Rush, Andrew A Nierenberg, et al.
Pageof 21